Results
623
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
623 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$176.04 | -4.2% | 52.0% | US$55.1b | US$185.31 | PE82.2x | E38.4% | 2.1% | Diversified Financials | ||
RHM | €611.60 | -2.0% | 114.8% | €26.6b | €721.93 | PE38.8x | E29.9% | 0.9% | Capital Goods | ||
NVDA | US$134.70 | 2.0% | 175.9% | US$3.3t | US$172.80 | PE52.3x | E25.1% | 0.03% | Semiconductors | ||
SRPT | US$118.97 | -6.2% | 25.8% | US$11.4b | US$185.10 | PE93.3x | E43.0% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$57.14 | -1.3% | 103.9% | US$18.3b | US$59.48 | PE129.6x | E29.4% | n/a | Consumer Durables | ||
CRDO | US$68.51 | -11.3% | 245.8% | US$11.5b | US$73.54 | PS46.7x | E66.3% | n/a | Semiconductors | ||
ALNY | US$245.44 | 0.6% | 28.5% | US$31.7b | US$299.11 | PS15.1x | E70.3% | n/a | Pharmaceuticals & Biotech | ||
9992 | HK$88.90 | -6.7% | 361.6% | HK$117.9b | HK$91.37 | PE72.5x | E35.3% | 0.3% | Retail | ||
600760 | CN¥48.49 | -1.9% | 11.7% | CN¥133.6b | CN¥53.90 | PE54.3x | E29.3% | 0.8% | Capital Goods | ||
MRVL | US$111.90 | -10.3% | 85.7% | US$96.8b | US$120.80 | PS18x | E69.5% | 0.2% | Semiconductors | ||
NU | US$10.38 | -11.6% | 26.3% | US$49.9b | US$15.54 | PB6.5x | E28.6% | n/a | Banks | ||
300308 | CN¥132.59 | 8.0% | 66.9% | CN¥140.4b | CN¥191.56 | PE31.6x | E32.6% | 0.2% | Tech | ||
SUZLON | ₹63.86 | -3.8% | 71.4% | ₹875.2b | ₹74.83 | PE90.8x | E39.4% | n/a | Capital Goods | ||
511243 | ₹1,171.15 | -8.9% | -6.3% | ₹984.6b | ₹1,518.12 | PE25.6x | E21.9% | 0.2% | Diversified Financials | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
BESI | €130.60 | 2.6% | -5.2% | €10.4b | €137.18 | PE58.6x | E30.2% | 1.6% | Semiconductors | ||
FM | CA$18.81 | 1.1% | 70.2% | CA$15.6b | CA$21.94 | PS2.3x | E72.9% | n/a | Materials | ||
A196170 | ₩277,000.00 | -10.8% | 215.1% | ₩14.8t | ₩565,000.00 | PS198.5x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
300502 | CN¥124.65 | -5.7% | 152.0% | CN¥88.4b | CN¥151.97 | PE46.4x | E36.7% | 0.1% | Tech | ||
ARGX | €604.60 | -0.2% | 79.5% | €36.5b | €596.31 | PS20x | E55.7% | n/a | Pharmaceuticals & Biotech | ||
BAM | CA$78.25 | -6.5% | 48.3% | CA$32.9b | CA$74.64 | PE50.9x | E88.3% | 2.8% | Diversified Financials | ||
KSPI | US$98.70 | -4.4% | 9.7% | US$18.8b | US$133.84 | PE10.1x | E23.7% | 6.6% | Diversified Financials | ||
SMCI | US$31.59 | -5.5% | 9.0% | US$18.5b | US$41.93 | PE15.3x | E24.3% | n/a | Tech | ||
SOLARINDS | ₹9,685.75 | -8.0% | 46.9% | ₹885.7b | ₹11,698.00 | PE86.7x | E27.0% | 0.09% | Materials |